Oxybutynin Chloride Patent Expiration
Oxybutynin Chloride is Used for managing incontinence, hormone replacement therapy, treating involuntary incontinence, managing overactive bladder, and increasing compliance in patients. It was first introduced by Ortho Mcneil Janssen Pharmaceuticals Inc
Oxybutynin Chloride Patents
Given below is the list of patents protecting Oxybutynin Chloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ditropan Xl | US5674895 | Dosage form comprising oxybutynin |
May 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl |
US5674895 (Pediatric) | Dosage form comprising oxybutynin |
Nov 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl | US5840754 | Dosage form comprising oxybutynin |
May 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl |
US5840754 (Pediatric) | Dosage form comprising oxybutynin |
Nov 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl | US5912268 | Dosage form and method for treating incontinence |
May 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl |
US5912268 (Pediatric) | Dosage form and method for treating incontinence |
Nov 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl | US6262115 | Method for the management of incontinence |
May 22, 2015
(Expired) | Janssen Pharms |
| Ditropan Xl |
US6262115 (Pediatric) | Method for the management of incontinence |
Nov 22, 2015
(Expired) | Janssen Pharms |
| Gelnique | US10272061 | Compositions and methods for unoccluded transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
| Gelnique | US10449173 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Nov 06, 2029 | Abbvie |
| Gelnique | US7029694 | Compositions and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
| Gelnique | US7179483 | Compositions and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
| Gelnique | US8241662 | Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
| Gelnique | US8920392 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Mar 26, 2031 | Abbvie |
| Gelnique | US9259388 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Nov 06, 2029 | Abbvie |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Oxybutynin Chloride Generics
Several generic applications have been filed for Oxybutynin Chloride. The first generic version for Oxybutynin Chloride was by Usl Pharma Inc and was approved on Mar 10, 1988. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Feb 7, 2023.
Given below is the list of companies who have filed for Oxybutynin Chloride generic.
1. BEXIMCO PHARMS USA
Beximco Pharmaceuticals Usa Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jul 14, 2022 |
2. PHARM ASSOC
Pharmaceutical Associates Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/5ML | syrup | Discontinued | ORAL | N/A | Dec 18, 1998 |
3. LANNETT CO INC
Lannett Co Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/5ML | syrup | Discontinued | ORAL | N/A | Dec 28, 2004 |
4. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Dec 17, 2020 |
5. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Unique.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
6. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
7. IMPAX PHARMS
Impax Pharmaceuticals has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Impax Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | May 9, 2007 |
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | May 9, 2007 |
8. OSMOTICA PHARM US
Osmotica Pharmaceutical Us Llc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Osmotica Pharm Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
9. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Nov 14, 1988 |
10. ABHAI LLC
Abhai Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Abhai Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Dec 22, 2017 |
11. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 19, 1989 |
12. QUANTUM PHARMICS
Quantum Pharmics Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Quantum Pharmics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 8, 1988 |
13. AVET LIFESCIENCES
Avet Lifesciences Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | May 10, 2019 |
14. TULEX PHARMS INC
Tulex Pharmaceuticals Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Tulex Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Sep 6, 2018 |
15. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |
16. LEADING
Leading Pharma Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Leading.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Apr 6, 2020 |
17. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
| 15MG
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
18. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
19. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/5ML | syrup | Prescription | ORAL | AA | Jan 29, 1999 |
| 10% (100MG/PACKET) | gel | Discontinued | TRANSDERMAL | N/A | May 31, 2018 |
20. USL PHARMA
Usl Pharma Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Usl Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Mar 10, 1988 |
21. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
22. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 23, 2017 |
23. RUBICON
Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
| 10MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
| 5MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
24. EYWA
Eywa Pharma Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Eywa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Feb 6, 2019 |
25. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc. has filed for 2 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | May 10, 2007 |
26. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
27. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Dec 21, 2017 |
| 2.5MG
(reference standard) | tablet | Prescription | ORAL | N/A | Feb 7, 2023 |
28. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jul 31, 1996 |
29. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 30, 2019 |
30. PHARMOBEDIENT CNSLTG
Pharmobedient Consulting has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/5ML | syrup | Discontinued | ORAL | N/A | Feb 12, 1997 |